StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.48−0.08 (-5.13%)

Close on Nov 17, 2026Market cap $526.23MP/E –Yield –

Evotec operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -€9.18M, down 150.4% from the year before. The highest annual figure on record is €205.81M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€9.18M-150.4%
FY2024Dec 31, 2024€18.22M-50.0%
FY2023Dec 31, 2023€36.44M-82.3%
FY2022Dec 31, 2022€205.81M+62.6%
FY2021Dec 31, 2021€126.60M+183.1%
FY2020Dec 31, 2020€44.72M+5.9%
FY2019Dec 31, 2019€42.22M–

More Evotec figures

See a number that looks wrong?